ARTICLES
Randomized trials in the treatment of cancer of the esophagus
DJ Girling and PI Clark
JCO Jul 1 1992: 1031–1033. [PDF]
The HER-2/neu oncogene in breast cancer: so what is new?
MN Levine and I Andrulis
JCO Jul 1 1992: 1034–1036. [PDF]
	Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery [published erratum appears in J Clin Oncol 1992 Nov;10(11):1822]
	PG Gill, JW Denham, GG Jamieson, PG Devitt, E Yeoh, and C Olweny
	JCO Jul 1 1992: 1037–1043. [Abstract] [PDF]
	Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up
	S Toikkanen, H Helin, J Isola, and H Joensuu
	JCO Jul 1 1992: 1044–1048. [Abstract] [PDF]
	Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group
	BA Gusterson, RD Gelber, A Goldhirsch, KN Price, J Save-Soderborgh, R Anbazhagan, J Styles, CM Rudenstam, R Golouh, and R Reed
	JCO Jul 1 1992: 1049–1056. [Abstract] [PDF]
	Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen
	L Daly, J Ferguson, GP Cram, Jr, V Hars, SL George, KS McCarty, Jr, and RC Bast, Jr
	JCO Jul 1 1992: 1057–1065. [Abstract] [PDF]
	A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study [published erratum appears in J Clin Oncol 1993 Feb;11(2):384]
	Sr Loehrer PJ, LH Einhorn, PJ Elson, ED Crawford, P Kuebler, I Tannock, D Raghavan, R Stuart-Harris, MF Sarosdy, and BA Lowe
	JCO Jul 1 1992: 1066–1073. [Abstract] [PDF]
	Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study
	B Jeremic, D Grujicic, S Jevremovic, B Stanisavljevic, L Milojevic, L Djuric, and L Mijatovic
	JCO Jul 1 1992: 1074–1077. [Abstract] [PDF]
	Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients
	P Morel, E Lepage, P Brice, B Dupriez, MF D'Agay, P Fenaux, B Gosselin, F Bauters, and C Gisselbrecht
	JCO Jul 1 1992: 1078–1085. [Abstract] [PDF]
	High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease
	JM Tourani, R Levy, P Colonna, B Desablens, PY Leprise, F Guilhot, S Brahimi, M Belhani, N Ifrah, and L Sensebe
	JCO Jul 1 1992: 1086–1094. [Abstract] [PDF]
	Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status
	RK Mulhern, E Kovnar, J Langston, M Carter, D Fairclough, L Leigh, and LE Kun
	JCO Jul 1 1992: 1095–1102. [Abstract] [PDF]
	A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study
	WR Vogler, E Velez-Garcia, RS Weiner, MA Flaum, AA Bartolucci, GA Omura, MC Gerber, and PL Banks
	JCO Jul 1 1992: 1103–1111. [Abstract] [PDF]
	Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial
	P Rougier, A Laplanche, M Huguier, JM Hay, JM Ollivier, J Escat, R Salmon, M Julien, JC Roullet Audy, and D Gallot
	JCO Jul 1 1992: 1112–1118. [Abstract] [PDF]
	Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis
	DT Sleijfer, RA Janssen, J Buter, EG de Vries, PH Willemse, and NH Mulder
	JCO Jul 1 1992: 1119–1123. [Abstract] [PDF]
	A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma [published erratum appears in J Clin Oncol 1992 Nov;10(11):1822]
	DH Ilson, RJ Motzer, RL Kradin, NJ Vogelzang, DF Bajorin, HI Scher, D Nanus, P O'Moore, K Marathias, and GJ Bosl
	JCO Jul 1 1992: 1124–1130. [Abstract] [PDF]
	Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study
	PE Postmus, JA Gietema, O Damsma, B Biesma, PC Limburg, E Vellenga, and EG de Vries
	JCO Jul 1 1992: 1131–1140. [Abstract] [PDF]
	The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies
	JW Smith, 2d, WJ Urba, BD Curti, LJ Elwood, RG Steis, JE Janik, WH Sharfman, LL Miller, RG Fenton, and KC Conlon
	JCO Jul 1 1992: 1141–1152. [Abstract] [PDF]
	The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b
	PA Kosmidis, CN Baxevanis, N Tsavaris, M Papanastasiou, E Anastasopoulos, C Bacoyiannis, N Mylonakis, N Karvounis, D Bafaloukos, and A Karabelis
	JCO Jul 1 1992: 1153–1157. [Abstract] [PDF]
	Association of HLA phenotype with response to active specific immunotherapy of melanoma
	MS Mitchell, W Harel, and S Groshen
	JCO Jul 1 1992: 1158–1164. [Abstract] [PDF]
	Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer
	G Sarosy, E Kohn, DA Stone, M Rothenberg, J Jacob, DO Adamo, FP Ognibene, RE Cunnion, and E Reed
	JCO Jul 1 1992: 1165–1170. [Abstract] [PDF]
	Influence of sex and age on fluorouracil clearance
	G Milano, MC Etienne, E Cassuto-Viguier, A Thyss, J Santini, M Frenay, N Renee, M Schneider, and F Demard
	JCO Jul 1 1992: 1171–1175. [Abstract] [PDF]
	Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients [published erratum appears in J Clin Oncol 1992 Dec;10(12):1988]
	MC Etienne, G Milano, M Frenay, N Renee, E Francois, A Thyss, M Schneider, and M Namer
	JCO Jul 1 1992: 1176–1182. [Abstract] [PDF]
	Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans
	J Robert, JP Armand, S Huet, M Klink-Alakl, G Recondo, and P Hurteloup
	JCO Jul 1 1992: 1183–1190. [Abstract] [PDF]
	Prevention of graft-versus-host disease by selective depletion of CD6- positive T lymphocytes from donor bone marrow
	RJ Soiffer, C Murray, P Mauch, KC Anderson, AS Freedman, SN Rabinowe, T Takvorian, MJ Robertson, N Spector, and R Gonin
	JCO Jul 1 1992: 1191–1200. [Abstract] [PDF]
Impact of time on cosmetic outcome following breast-conserving therapy
FA Vicini and A Martinez
JCO Jul 1 1992: 1201. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	A Population-Based Study of Neuroblastoma Incidence, Survival, and Mortality in North America
	Mark L. Bernstein, Jean Marie Leclerc, Greta Bunin, Linda Brisson, Les Robison, Jonathan Shuster, Tim Byrne, Diana Gregory, Gerry Hill, Geoff Dougherty, Charles Scriver, Bernard Lemieux, Mendel Tuchman, and William G. Woods
	JCO Jul 1 1992: 1202. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.